Title
Mutation-based growth charts for SEDC and other COL2A1 related dysplasias
Author
Terhal, P.A.
van Dommelen, P.
Le Merrer, M.
Zankl, A.
Simon, M.E.
Smithson, S.F.
Marcelis, C.
Kerr, B.
Kinning, E.
Mansour, S.
Hennekam, R.C.
van der Hout, A.H.
Cormier-Daire, V.
Lund, A.M.
Goodwin, L.
Mégarbané, A.
Lees, M.
Betz, R.C.
Tobias, E.S.
Coucke, P.
Mortier, G.R.
Publication year
2012
Abstract
From data collected via a large international collaborative study, we have constructed a growth chart for patients with molecularly confirmed congenital spondylo-epiphyseal dysplasia (SEDC) and other COL2A1 related dysplasias. The growth chart is based on longitudinal height measurements of 79 patients with glycine substitutions in the triple-helical domain of COL2A1. In addition, measurements of 27 patients with other molecular defects, such as arginine to cysteine substitutions, splice mutations, and mutations in the C-terminal propeptide have been plotted on the chart. Height of the patients progressively deviate from that of normal children: compared to normal WHO charts, the mean length/height is -2.6 SD at birth, -4.2 SD at 5 years, and -5.8 SD in adulthood. The mean adult height (male and female combined) of patients with glycine substitutions in the triple-helical region is 138.2cm but there is a large variation. Patients with glycine to cysteine substitutions tend to cluster within the upper part of the chart, while patients with glycine to serine or valine substitutions are situated between +1 SD and -1 SD. Patients with carboxy-terminal glycine substitutions tend to be shorter than patients with amino-terminal substitutions, while patients with splice mutations are relatively tall. However, there are exceptions and specific mutations can have a strong or a relatively mild negative effect on growth. The observation of significant difference in adult height between affected members of the same family indicates that height remains a multifactorial trait even in the presence of a mutation with a strong dominant effect. © 2012 Wiley Periodicals, Inc. Molecular Sequence Numbers: GENBANK: NM_001844; Chemicals/CAS: arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; asparagine, 70-47-3, 7006-34-0; cysteine, 4371-52-2, 52-89-1, 52-90-4; glycine, 56-40-6, 6000-43-7, 6000-44-8; valine, 7004-03-7, 72-18-4
Subject
Human
LS - Life Style
BSS - Behavioural and Societal Sciences
Healthy for Life
Health
Healthy Living
COL2A1
Growth
Spondylo-epiphyseal dysplasia congenita
arginine
asparagine
cysteine
glycine
valine
adult
adulthood
amino acid substitution
amino terminal sequence
anthropometric parameters
article
carboxy terminal sequence
child
codon
Col2a1 gene
female
gene
gene mutation
growth curve
human
major clinical study
male
nucleotide sequence
preschool child
priority journal
spondyloepiphyseal dysplasia
To reference this document use:
http://resolver.tudelft.nl/uuid:7a0508d9-ed55-45ec-b6bb-cb2ed6d2ee69
DOI
https://doi.org/10.1002/ajmg.c.31332
TNO identifier
462855
ISSN
1552-4868
Source
American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 160 C (3), 205-216
Document type
article